Get the Stockscreener App
6.17
161.44%
3.81
After Hours:
5.93
-0.24
-3.89%
Cervomed Inc Stock (CRVO) Latest News
Chardan lifts CervoMed stock rating to Buy, targets $14 - Investing.com India
CervoMed upgraded to Buy from Neutral at Chardan - TipRanks
EU's tariffs will be 'devastating' for spirits sector, industry says - info-mods.com
The maker of Roomba has ‘substantial doubt’ about surviving - CNN
CervoMed (NASDAQ:CRVO) Given New $15.00 Price Target at Roth Mkm - Defense World
CervoMed Inc.'s (NASDAQ:CRVO) Price Is Right But Growth Is Lacking - Simply Wall St
CervoMed’s (CRVO) Buy Rating Reaffirmed at D. Boral Capital - Defense World
CervoMed Shares Business and Financial Updates Online - TipRanks
Brookline raises CervoMed stock rating to buy, sets $16 target - Investing.com
Mineralys aims to raise $250M; Coherus discloses layoffs - Endpoints News
Brookline raises CervoMed stock rating to buy, sets $16 target By Investing.com - Investing.com UK
Trump says he’ll buy a Tesla to support Elon Musk, whose companies are struggling - CNN
Brookline Capital Upgrades CervoMed to Buy From Hold, Price Target is $16 -March 11, 2025 at 08:46 am EDT - Marketscreener.com
CervoMed price target raised to $15 from $7 at Roth MKM - TipRanks
CervoMed reports positive results from dementia trial - The Pharma Letter
Dementia drug neflamapimod shows positive phase 2b trial results - PharmaTimes
Who is Mark Carney, the crisis-handling former central bank governor turned Canada’s next leader? - CNN
CervoMed announces results from extension phase of RewinD-LB study - TipRanks
CervoMed Reports Positive Phase 2b Trial Results - TipRanks
CervoMed Inc. Reports Positive Results from Extension Phase of Phase 2b RewinD-LB Study for Neflamapimod in Dementia with Lewy Bodies - Nasdaq
CervoMed Announces Positive Results from the Extension - GlobeNewswire
CVS is opening smaller stores that only have pharmacies - CNN
Analysts Set CervoMed Inc. (NASDAQ:CRVO) PT at $37.43 - Defense World
The US Postal Service is more efficient than you think. Privatizing it could cause problems for many - CNN
Musk’s Starlink gets FAA contract, raising new conflict of interest concerns - CNN
MSNBC announces major lineup overhaul, new Washington bureau as Joy Reid exits company - CNN
CervoMed (NASDAQ:CRVO) Raised to Buy at D. Boral Capital - Armenian Reporter
Boral Capital raises CervoMed stock to Buy, sets $10 target By Investing.com - Investing.com Australia
Why CervoMed (CRVO) Is Advancing Today - Yahoo Canada Finance
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Boral Capital raises CervoMed stock to Buy, sets $10 target - Investing.com
How Are Things Looking For CervoMed Inc (NASDAQ: CRVO) For The Short Term? - Stocks Register
CervoMed Inc. (NASDAQ:CRVO) Receives $42.00 Average PT from Brokerages - Defense World
BIO CEO 2025: Cognition CEO debates policy while advancing CT-1812 - BioWorld Online
Perigon Wealth Management LLC Makes New Investment in CervoMed Inc. (NASDAQ:CRVO) - Defense World
CervoMed Provides Update on Neflamapimod DLB Program as - GlobeNewswire
CervoMed reports progress in dementia drug trial - MSN
CervoMed Updates on Neflamapimod Trials for Dementia - TipRanks
CervoMed reports progress in dementia drug trial By Investing.com - Investing.com UK
Clinical Trial Setback: CervoMed's Dementia Drug Gets Second Chance with Enhanced Formula - StockTitan
CervoMed to Present at the 8th International Lewy Body Dementia Conference - GlobeNewswire
Major Breakthrough in Lewy Body Dementia Treatment: CervoMed Reveals Game-Changing Clinical Data - StockTitan
CervoMed Inc. (NASDAQ:CRVO) Stock Holdings Lifted by Barclays PLC - Defense World
Roth MKM Initiates Coverage of CervoMed (CRVO) with Buy Recommendation - MSN
CervoMed Inc. (NASDAQ:CRVO) Receives $42.00 Average Price Target from Analysts - Defense World
AWM Investment Company, Inc. Reduces Stake in CervoMed Inc - GuruFocus.com
CervoMed (STU:DP8) Momentum Rank : 8 (As of Jan. 11, 2025) - GuruFocus.com
Geode Capital Management LLC Raises Holdings in CervoMed Inc. (NASDAQ:CRVO) - Defense World
Barclays PLC Acquires 5,919 Shares of CervoMed Inc. (NASDAQ:CRVO) - Defense World
Brookline Capital Initiates Coverage of CervoMed (CRVO) with Buy Recommendation - MSN
State Street Corp Boosts Stake in CervoMed Inc. (NASDAQ:CRVO) - Defense World
Analysts Set CervoMed Inc. (NASDAQ:CRVO) Price Target at $42.00 - Defense World
HC Wainwright Brokers Reduce Earnings Estimates for CervoMed - Defense World
Enhanced Cognition: Lewy body dementia phase II pumps stock - BioWorld Online
HC Wainwright & Co. Downgrades CervoMed (CRVO) - MSN
3.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):